|
RTGN Retinalgenix Technologies Inc 1836295 |
| Income Statement |
|
Net Income
|
form10-q
|
-644,291 |
| Balance Sheet |
|
Current Assets
|
79,089 |
|
Assets
|
88,854 |
|
Current Liabilities
|
1,936,140 |
|
Liabilities
|
1,943,168 |
|
Equity
|
-1,854,314 |
|
Shares Out
|
17,996,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-555,546 |
| Market Analysis |
Market Cap
|
62,511,670 |
|
Price
|
2.01 |
|
BVPS
|
0.55 |
|
PB
|
3.63 |
|
EPS
|
-0.23 |
|
PS
|
0.06 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RTGN documents filed with the SEC.
RTGN Filings
Clear
